Jacqueline receives funded R21 , and has had an abstract accepted for 18th World Congress of the International Pancreas and Islet Transplant Association.

Jacqueline Burke’s R21 "Identification of the immunomodulatory mechanisms of nanocarrier-enhanced costimulation blockade in an allogeneic portal vein islet transplantation mode" has been funded.

In addition, Jacqueline’s abstract "Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability" was accepted for oral presentation at the 18th World Congress of the International Pancreas and Islet Transplant Association.

Congratulations Jacqueline!